High neuroligin levels also correlate with high levels of prostate-specific antigen (PSA) and Gleason grading, both associated with more aggressive disease, suggesting that NRG1 could be a marker for predicting progression of prostate cancer [51]. The gene discussed is NRG1; the disease is prostate cancer.